The summer of 2022 has witnessed a number of significant developments in the pharmaceuticals and healthcare sector in Turkey. The Turkish Medicine and Medical Devices Authority (“Authority”) has issued guidelines and announcements with a view to aligning with the international standards and addressing the
commonly encountered procedural issues.
You can reach full of the briefing here.
Share
Related persons
You can contact us for detailed information.
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
28 January 2025
Recent developments in Turkish data protection law
The end of 2024 and the beginning of 2025 were highly active in terms of developments in data protection legislation in Türkiye. Many…
13 January 2025
New Administrative Fines Regulation For Competition Violations Enters Into Force
The Regulation on Administrative Fines for Restrictive Agreements, Concerted Practices, Decisions, and Abuse of Dominance, which governs…
9 January 2025
Türkiye Strengthens Anti-Money Laundering Standards for Crypto Assets
Following the legal framework established for crypto assets and crypto asset service providers ("CASPs") under the Capital Markets Law No.…
6 January 2025
Thresholds for Initial Public Offerings Increased
As per the decision of the Capital Markets Board (the “CMB”) published in its bulletin dated 31 December 2024, the financial thresholds…
30 December 2024
Legal Briefing on Recent Developments in the Electricity Market
With the Regulation on Aggregation Activities in the Electricity Market, published in the Official Gazette dated 17 December 2024 and…
23 December 2024
Transfer of Marketing Authorisations for Medicinal Products
Under Turkish law, only entities registered in Türkiye are eligible to obtain a marketing authorization (“MA”) for medicinal products for…